$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Gastroenterology
Gastroenterology
服用耐信的注意事项
2025-10-19 11:44:20
Check Details
耐信吃多久?
2025-10-19 11:44:20
Check Details
日本耐信售价多少?
2025-10-19 11:44:20
Check Details
耐信国内有吗?
2025-10-19 11:44:20
Check Details
耐信上市没?
2025-10-19 11:44:20
Check Details
耐信用量多少?
2025-10-19 11:44:20
Check Details
耐信的作用和副作用
2025-10-19 11:44:20
Check Details
耐信的用法用量
2025-10-19 11:44:20
Check Details
耐信2020价格
2025-10-19 11:44:20
Check Details
埃索美拉唑(耐信)的价格
2025-10-19 11:44:20
Check Details
埃索美拉唑(耐信)多少钱
2025-10-19 11:44:20
Check Details
埃索美拉唑(耐信)好不好
2025-10-19 11:44:20
Check Details
1
2
...
38
39
40
41
42
43
44
...
57
58
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Etrasimod for Ulcerative Colitis: 2mg Once Daily, Onset Timeline, and Safety Monitoring
2
Lusutrombopag Safety and Dosing: Thrombosis Risk and Indications
3
Resmetirom Indication Clarification: Approved for NASH Fibrosis, Not Hepatitis B Cirrhosis
4
Filgotinib: Mechanism of Action and Clinical Applications Explained
5
Elafibranor for Primary Biliary Cholangitis: Indication, Dosing, and Safety Overview
6
Lusutrombopag: An Oral Pre-procedural Option for Thrombocytopenia in Chronic Liver Disease
7
Lusutrombopag: Complete Guide to Dosage, Administration and Clinical Monitoring
8
Resmetirom (Rezdiffra) Safety Guide: Hepatotoxicity, Gallbladder Risks & Statin Interactions Explained
9
Etrasimod (Velsipity™): A Selective S1P Modulator Transforming Ulcerative Colitis Treatment
10
Elafibranor for Cholestatic Liver Diseases: Efficacy Maintenance and Drug Resistance Analysis
11
How much is the latest price of a box of Nadimedine in 2025?
12
What are the purchasing channels for Nadimedin?